AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Co... ( About Nektar Nektar Ther...)

HOME >> BIOLOGY >> TECHNOLOGY

AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation

Date:9/21/2009

www.astrazeneca.com

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar's technology and drug development expertise have enabled nine approved products in the U.S. or Europe for partners, which include leading biopharmaceutical companies, including UCB's Cimzia(R), Roche's PEGASYS(R) for hepatitis C and Amgen's Neulasta(R) for neutropenia. Nektar has created a robust pipeline of potentially high-value therapeutics to address unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecules. Nektar is currently conducting clinical and preclinical programmes in oncology, pain and other therapeutic areas. NKTR-102, PEGylated irinotecan, is currently in Phase 2 clinical studies in ovarian, breast and colorectal cancer. NKTR-105, PEGylated docetaxel, is currently in a Phase 1 clinical study in patients with refractory solid tumors.

Nektar is headquartered in San Carlos, California, with additional R&D operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programmes and capabilities may be found online at http://www.nektar.com.

Nektar Investor Enquiries:
Jennifer Ruddock/Nektar Therapeutics +1 650-631-4954
Susan Noonan/SAN Group (212) 966-3650

Nektar Media Enquiries:
Karen Bergman/BCC Partners (650) 575-1509
Michelle Corral/BCC Partners (415) 794-8662

AZ Media Enquiries:
Neil McCrae +44 20 7304 5045 (24 hours)
Chris Sampson
'/>"/>
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved
0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Pediatric Asthma Programs Featuring PARI Pharmas eFlow Acquired by AstraZeneca
2. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
3. AstraZeneca and Banner Alzheimers Institute Collaborate to Evaluate New Tool Targeting Alzheimers Disease
4. Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development
5. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
6. AstraZeneca Response to February 21, 2008 Ruling In Re: Alabama Medicaid Pharmaceutical AWP Litigation - cv2005-219 - Circuit Court of Montgomery, Alabama
7. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
8. AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
9. Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
10. AstraZenecas Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer by 2016
11. Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation

Post Your Comments:

(Date:11/18/2009)... Imagine a polka-dotted postage stamp that can sn... changing colors. , As reported in the Sept. 13 ...uslick and his team at the University of Illinois ...detection of toxic industrial chemicals (TICs) tha...sualizing odors. This sensor array could be usefu...

(Date:11/18/2009)...er,s experience in data analysis combined with Bio... kits and curricula provide state-of-the-art s...TON, Ore., Nov. 18 Vernier Softwar...nce interfaces, sensors, and software and Bio-Rad ...nd distributor of life science research and clinic...

(Date:11/18/2009)... YORK, Nov. 18 Reportlinker.com an...able in its catalogue. ,, Biotechnology Reage.../www.reportlinker.com/p0164375/Biotechnology-Reage...prnewswire&utm_medium=pr&utm_campaign=prne...complex chemical compounds used in a range of biot...

(Date:11/18/2009)... SPRINGS, Fla., Nov. 18 Algenol Bi...technology, and the technology group The Linde G...ment project in order to identify the optimum mana... Algenol,s unique algae and photobioreactor techno... forces to develop cost-efficient technologies tha...

Breaking Biology Technology:Opto-electronic nose sniffs out toxic gases 2 Opto-electronic nose sniffs out toxic gases 3 Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7 Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8 Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 2 Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 3

[0] Opto-electronic nose sniffs out toxic gases [0] Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education [0] Reportlinker Adds Biotechnology Reagents - A Global Market Perspective [0] Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae

...nce at the EuroPCR08 will highlight choice of diff...tegrated imaging platform., SAN DIEGO, and BRUSSE... VOLC ), a leading manufacturer and developer of,i...ment (FM) and Optical,Coherence Tomography (OCT) p...tment of coronary and peripheral vascular disease,...

...ORK and PARSIPPANY, N.J., May 12 Forest,Laborator...al company, and,Daiichi Sankyo, Inc. today announc...reement for AZOR(TM)* (amlodipine and olmesartan m...of two antihypertensives, the,calcium channel bloc...or,blocker olmesartan medoxomil. Forest will recor...

...ference Call at 10:30 a.m. ET, May 13 -, EMERYVIL...Inc. (NTI(R)) (Nasdaq: NTII ) today announced fin...e nine months ended March 31,2008., Revenues for ...llion,compared to $4.9 million for the same three ...ses were $5.9 million for the third,quarter of 200...

Other Biology Technology:Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 2 Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 3 Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 4 Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 2 Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 3 Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 4 Neurobiological Technologies Reports Third Quarter Financial Results 2 Neurobiological Technologies Reports Third Quarter Financial Results 3 Neurobiological Technologies Reports Third Quarter Financial Results 4 Neurobiological Technologies Reports Third Quarter Financial Results 5

Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement Neurobiological Technologies Reports Third Quarter Financial Results

(Date:11/20/2009)...Research Center (ERC) has been awarded a grant fro...ethods of recovering and reusing the heat that wou...ression process in a carbon capture system. The go... capture and sequestration, or storage (CCS), and ...emitted into the atmosphere by coal-fired power pl...

(Date:11/19/2009)...which cultivate fungus for food, have many remarka... list: the ant farmers, like their human counterpa...eir gardens grow. The finding, reported this week ...eviously unknown symbiosis between ants and bacter...have come to dominate the American tropics and sub...

(Date:11/19/2009)...A four-year, multi-institutional effort co-led by ...sts culminated today in publication of a landmark ...g in unprecedented detail the DNA sequence of maiz...called by North American consumers, is one of the ...e agricultural crop grown in the United States, re...

Breaking Biology News(10 mins):Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2 Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3 Like humans, ants use bacteria to make their gardens grow 2 Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2 Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3 Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4 China Pharma Holdings Inc to Report Second Quarter 2009 Financial Results on August 12 2009 53068 1 China Pharma Holdings Inc to Report Second Quarter 2009 Financial Results on August 12 2009 53068 2 Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America 53066 1 Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America 53066 2 Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America 53066 3 Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America 53066 4 Patriot Scientific Corporation Announces Cardiac Science Corporations Purchase of a Moore Microprocessor Patent 28TM 29 Portfolio License 53064 1 Patriot Scientific Corporation Announces Cardiac Science Corporations Purchase of a Moore Microprocessor Patent 28TM 29 Portfolio License 53064 2

[0] Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants [1] Like humans, ants use bacteria to make their gardens grow [0] Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists

... young gene known as sphinx is inactivated in the ...courtship, scientists report in the May 27, 2008, ...f Sciences. , High levels of male-male courtship ...sophila melanogaster, the tiny insect that has bee...entury. , In 2002, the research team of Manyuan ...

...mproved resolution, tissue-specific molecular mark...gist James A. Weston and colleagues have possibly ...igin of embryonic cells that give rise to connecti...skull and facial structures in back-boned creature...om the Max Planck Institute of Immunology in Germa...

...ON, Mich.---Armed with chainsaws and pry bars, Uni...es recently hastened the end for nearly 7,000 matu...rm experiment to glimpse the Great Lakes region,s ...m each tree to kill it without cutting it down. , ...Forest Accelerated Succession Experiment (FASET) i...

Other Biology News:Courtship pattern shaped by emergence of a new gene in fruit flies 2 Origin of cells for connective tissues of skull and face challenged 2 Origin of cells for connective tissues of skull and face challenged 3 U-M scientists remove thousands of aspens to glimpse forest's future 2 U-M scientists remove thousands of aspens to glimpse forest's future 3

Courtship pattern shaped by emergence of a new gene in fruit flies Origin of cells for connective tissues of skull and face challenged U-M scientists remove thousands of aspens to glimpse forest's future

Peptone from Sigma-Aldrich

SmartSpec 3000 Spectrophotometer from Bio-Rad

Propidium Iodide Staining Solution Solution from BD Biosciences Pharmingen

BD Biocoat Matrigel Matrix Thin Layer 35 mm Culture Dishes from BD Biosciences - Discovery Labware

Biology Products:

Peptone from Sigma-Aldrich SmartSpec 3000 Spectrophotometer from Bio-Rad Propidium Iodide Staining Solution Solution from BD Biosciences Pharmingen BD Biocoat Matrigel Matrix Thin Layer 35 mm Culture Dishes from BD Biosciences - Discovery Labware

AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Co...( About Nektar Nektar Ther...)